FDA rais­es ques­tions in ad­comm brief­ing docs for Roche's Po­livy la­bel ex­pan­sion

An FDA ad­vi­so­ry com­mit­tee is meet­ing on Thurs­day to weigh a po­ten­tial la­bel ex­pan­sion for Roche’s po­ten­tial block­buster Po­livy, but the agency has some con­cerns …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.